Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference39 articles.
1. Bar-Am O, Amit T, Youdim MBH: Contrasting neuroprotective and neurotoxic actions of respective metabolites of anti-Parkinson drugs rasagiline and selegiline. Neuroscience Lett. 2004, 355: 169-172. 10.1016/j.neulet.2003.10.067.
2. Bar-Am O, Amit T, Youdim MBH: Aminoindan and hydroxyaminoindan, metabolites of rasagiline and ladostigil, respectively, exert neuroprotective properties in vitro. J Neurochem. 2007, 103: 500-8. 10.1111/j.1471-4159.2007.04777.x.
3. Dimpfel W, Hoffmann JA: Electropharmacograms of Rasagiline, Its Metabolite Aminoindan and Selegiline in the Freely Moving Rat. Neuropsychobiol. 2010, 62: 213-220. 10.1159/000319947.
4. Youdim MB, Wadia A, Tatton W, Weinstock M: The anti-Parkinson drug rasagiline and its cholinesterase inhibitor derivatives exert neuroprotection unrelated to MAO inhibition in cell culture and in vivo. Ann N Y Acad Sci. 2001, 939: 450-8. 10.1111/j.1749-6632.2001.tb03656.x.
5. Bar-Am O, Winreb O, Amit T, Youdim MBH: The neuroprotective mechanism of 1-(R))-aminoindan, the major metabolite of the anti-Parkinsonian drug rasagiline. J Neurochem. 2009, 112: 113-7.
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献